kx01
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 27, 2015 (NCT05522816)
Timeline
Indications
Mechanism of action
- SRCANTAGONIST
SRC antagonist
- Tyrosine-protein kinase Fyn (FYN) ↗
- Proto-oncogene tyrosine-protein kinase Src (SRC) ↗
- Tyrosine-protein kinase Lck (LCK) ↗
- Tyrosine-protein kinase Yes (YES1) ↗
- Tyrosine-protein kinase Blk (BLK) ↗
- Tyrosine-protein kinase HCK (HCK) ↗
- Tyrosine-protein kinase Lyn (LYN) ↗
- Tyrosine-protein kinase FRK (FRK) ↗
- Tyrosine-protein kinase Fgr (FGR) ↗
- Tyrosine-protein kinase Srms (SRMS) ↗
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05231044 | Phase 3 | Dec 21, 2021 | PharmaEssentia Corp. |
| NCT05245578 | Phase 1 | Nov 16, 2021 | Medical Corporation HOUEIKAI, Sekino Clinical Pharmacology Clinic, PharmaEssentia Corp. |
| NCT05522816 | Phase 1 | Oct 27, 2015 | Athenex, Inc., China Medical University, National Taiwan University, PharmaEssentia Corp. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmaEssentia Corp. | For profit | 3 | 3 | 2 | 2015 |
| Athenex, Inc. | For profit | 1 | 0 | 1 | 2015 |
| China Medical University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Medical Corporation HOUEIKAI, Sekino Clinical Pharmacology Clinic | Academic/Hospital | 1 | 0 | 1 | 2021 |
| National Taiwan University | Academic/Hospital | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1